A series of discussions, organised by the Beckley Foundation’s collaboration with Imperial College London’s Neuropsychopharmacology unit, will be held on Wednesday 12th June at the university. Researches from around the world will be in attendance, presenting their latest findings and discussing new ideas arising as a result.
-
Psilocybin
This Program of research is part of a wider Beckley research program investigating the neurophysiological effects of psychedelics. In the first study we measured changes in brain blood flow after Psilocybin in 15 participants, using fMRI. The second study is investigating the use of Psilocybin in facilitating addiction treatment.
-
LSD
The Beckley Foundation was particularly proud to receive in spring 2007 the final approvals for the first study in over 30 years with human participants involving lysergic acid diethylamide (LSD). We have also been exploring the possibilities of using LSD for the treatment of pre-death anxiety and cluster headaches.
-
Cannabis
Cannabis is the most commonly used illicit drug worldwide and the pattern of usage has been steadily increasing over the past 40 years. This is why the Beckley Foundation has initiated an extensive research program investigating the effects users find beneficial, the efficacy of cannabis in medical use, and the opposite effects of the most significant compounds found ...
-
Cranial Compliance
Cranial compliance is a measure of the dynamic functioning of the cranial system as a whole: the skull, the brain tissue, and the two liquid volumes that flow through and around this complex system.
-
Meditation
Meditation is both an ancient spiritual practice and a contemporary technique for relaxing the body and calming the mind. Meditative techniques originally came from Asian religious practices and have been widely adopted in western society, where their health benefits have become widely recognised.
-
MDMA
MDMA is the pure form of street ‘ecstasy’. It causes a heightened sense of well-being and empathy, with relatively little effect on perception or...
